Literature DB >> 24376300

Transoral robotic surgery for retromolar trigone tumours.

K Durmus1, T Apuhan2, E Ozer1.   

Abstract

The retromolar trigone is a challenging transoral surgical site due to the difficulty of visualization. Our aim is to report a new technique of transoral robotic resection of retromolar trigone tumours. We present three patients with retromolar trigone tumours with pathological diagnosis of squamous cell carcinoma who underwent successful transoral robotic resection. Robotic retromolar trigone resection and concurrent supraomohyoid neck dissections were performed in all patients without any complication. In conclusion, transoral robotic surgery is a safe and feasible technique for resection of malignant retromolar trigone tumours with minimal complications and favourable outcomes.

Entities:  

Keywords:  Oral cavity; Retromolar trigone; TORS; Transoral robotic surgery

Mesh:

Year:  2013        PMID: 24376300      PMCID: PMC3870447     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  8 in total

Review 1.  Cancer of retromolar trigone: long-term radiation therapy outcome.

Authors:  C J Huang; K S Chao; J Tsai; J R Simpson; B Haughey; G J Spector; D G Sessions
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

2.  Robotic-assisted lingual tonsillectomy.

Authors:  Agnes Hurtuk; Theodoros Teknos; Enver Ozer
Journal:  Laryngoscope       Date:  2011-06-06       Impact factor: 3.325

3.  Treatment of squamous cell carcinoma of the retromolar trigone.

Authors:  Sheng-Po Hao; Ngan-Ming Tsang; Kai-Ping Chang; Chin-Kuo Chen; Shan-Sting Huang
Journal:  Laryngoscope       Date:  2006-06       Impact factor: 3.325

4.  Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.

Authors:  Tareck Ayad; Michel Gélinas; Louis Guertin; Daniel Larochelle; Pierre Del Vecchio; Jean-Claude Tabet; Marie-Jo Olivier; Denis Soulières; Danielle Charpentier; Phuc Félix Nguyen-Tân
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-07

5.  Transoral robotic surgery: radical tonsillectomy.

Authors:  Gregory S Weinstein; Bert W O'Malley; Wendy Snyder; Eric Sherman; Harry Quon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12

Review 6.  The natural evolution of endoscopic approaches in skull base surgery: robotic-assisted surgery?

Authors:  I Dallan; P Castelnuovo; C Vicini; M Tschabitscher
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-12       Impact factor: 2.124

7.  Transoral robotic surgery (TORS) for tongue base tumours.

Authors:  G Mercante; P Ruscito; R Pellini; G Cristalli; G Spriano
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

8.  Ectopic lingual goiter treated by transoral robotic surgery.

Authors:  R Pellini; G Mercante; P Ruscito; G Cristalli; G Spriano
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-10       Impact factor: 2.124

  8 in total
  4 in total

1.  Treatment Outcomes for Primary Retromolar Trigone Carcinoma: A Single Institution Experience.

Authors:  Uygar Levent Demir; Halide Öztürk Yanaşma
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-06-01

2.  p53 as a prognostic marker associated with the risk of mortality for oral squamous cell carcinoma.

Authors:  Tommaso Cutilli; Pietro Leocata; Vincenza Dolo; Emma Altobelli
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

3.  A novel approach emphasising intra-operative superficial margin enhancement of head-neck tumours with narrow-band imaging in transoral robotic surgery.

Authors:  C Vicini; F Montevecchi; G D'Agostino; A DE Vito; G Meccariello
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

4.  Impact of microvascular free flap reconstruction in oral cavity cancer: our experience in 130 cases.

Authors:  G Almadori; M Rigante; F Bussu; C Parrilla; R Gallus; L Barone Adesi; J Galli; G Paludetti; M Salgarello
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.